Protara Therapeutics to Participate in the Guggenheim Healthcare Talks 2022 Oncology Conference

Rhea-AI Summary

Protara Therapeutics, Inc. (Nasdaq: TARA) announced its participation in a virtual fireside chat at the Guggenheim Healthcare Talks 2022 Oncology Conference on February 9, 2022, at 4:00 PM ET. Interested parties can access the live webcast through the Events and Presentations section of the Company’s website, which will remain archived for 90 days post-event. Protara focuses on developing transformative therapies for cancer and rare diseases, including its lead program, TARA-002, aimed at treating non-muscle invasive bladder cancer and lymphatic malformations.

NEW YORK, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a virtual fireside chat at the Guggenheim Healthcare Talks 2022 Oncology Conference on February 9, 2022 at 4:00 PM ET.

A live webcast of the fireside chat can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived on the Company’s website for 90 days following the presentation.

About Protara Therapeutics, Inc.

Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options. Protara’s portfolio includes its lead program, TARA-002, an investigational cell-based therapy being developed for the treatment of non-muscle invasive bladder cancer and lymphatic malformations, and IV Choline Chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease. For more information, visit www.protaratx.com.

Company Contact:

Justine O'Malley
Protara Therapeutics
Justine.OMalley@protaratx.com
646-817-2836

FAQ

When is Protara Therapeutics participating in the Guggenheim Healthcare Talks Conference?

Protara Therapeutics will participate in the Guggenheim Healthcare Talks 2022 Oncology Conference on February 9, 2022, at 4:00 PM ET.

How can I access the Protara Therapeutics fireside chat?

You can access the fireside chat via a live webcast in the Events and Presentations section of Protara's website.

What is the focus of Protara Therapeutics' lead program TARA-002?

TARA-002 is being developed as a cell-based therapy for treating non-muscle invasive bladder cancer and lymphatic malformations.

What innovative therapies is Protara Therapeutics working on?

Protara Therapeutics is developing therapies for cancer and rare diseases, including TARA-002 and IV Choline Chloride for intestinal failure-associated liver disease.

Is the webcast of the Protara Therapeutics fireside chat available after the event?

Yes, the webcast will be archived on the Company's website for 90 days following the presentation.